The FDA is allowing Mark Cuban Cost Plus Drug Co. to temporarily import a syphilis drug that has been in shortage for more than a year.
Read the full post on Becker's Hospital Review | Healthcare News & Analysis
The FDA is allowing Mark Cuban Cost Plus Drug Co. to temporarily import a syphilis drug that has been in shortage for more than a year.
Read the full post on Becker's Hospital Review | Healthcare News & Analysis